Ori Biotech
Pierre Socha is the current director at Ori Biotech. Prior to their current position, they were the director at Charco. Before that, they were the director at Quibim.
Socha has also held positions at V7, Doctify, Inotec AMD, PhoreMost Ltd, Amadeus Capital Partners, and Lumeon.
Pierre Socha completed an executive program in Cleantech Ventures at the Massachusetts Institute of Technology, an executive program in Strategy & Competitive Advantage at Harvard Business School, and an executive program in Marketing at Stanford University Graduate School of Business. Pierre also holds a Master of Science in Environmental Economics from Aix-Marseille University and a Bachelor of Science in Finance & Econometrics (Math Specialization) from the University of Strasbourg.
This person is not in the org chart
This person is not in any offices
Ori Biotech
Ori Biotech is a London- and New Jersey-based innovator in CGT manufacturing that has developed a proprietary, bespoke and flexible manufacturing platform, which enables patient access to a new generation of personalized, life-saving treatments.